Af­ter M&A fell through, Ther­a­peu­tic­sMD sells hor­mone ther­a­py, con­tra­cep­tive ring for $140M cash plus roy­al­ties

Ther­a­peu­tic­sMD, a women’s health com­pa­ny whose one-time bil­lion-dol­lar val­u­a­tion seems a dis­tant mem­o­ry as its block­buster as­pi­ra­tions pe­tered out, is fi­nal­ly cash­ing out.

Aus­tralia’s Mayne …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER